Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More

Zinger Key Points
  • A comprehensive biweekly overview of major moves in business, science, trends and events in the psychedelics sector.

Welcome to Benzinga's psychedelic headlines roundup. This is our pick of must-read news items from the first two weeks of April 2024.

See previous edition Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More


  • Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases (original read.)
  • A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomes (original read.)
  • The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on (original read.)
  • Acute Adverse Effects of Therapeutic Doses of Psilocybin – A Systematic Review and Meta-Analysis (original read.)

Tune In, Get Smart

Panorama Pulse

Market News and Data brought to you by Benzinga APIs
Posted In: BiotechCannabisPsychedelicsPsychedelic-Assisted TherapiesPsychedelics ReformPsychedelics Research
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on – Prices will increase very soon!